Chordate Medical Holding

Mindre end 1K følgere

Oversigt

Investorkonsensus

Alle

Selskabsmeddelelser

ViserAlle indholdstyper

Selskabsmeddelelse18.2.2026, 14.30

Chordate’s application for delisting has been approved

Chordate Medical Holding

Selskabsmeddelelse18.2.2026, 12.25

Chordate applies for delisting

Chordate Medical Holding

Selskabsmeddelelse16.1.2026, 07.40

Chordate announces updated timetable for delisting

Chordate Medical Holding

Bliv en del af Inderes community

Gå ikke glip af noget - opret en konto og få alle de mulige fordele

Inderes konto

Følgere og notifikationer om fulgte virksomheder

Analytikerkommentarer og anbefalinger

Værktøj til at sammenligne aktier og andre populære værktøjer

Selskabsmeddelelse16.12.2025, 07.57

Chordate Medical terminates the liquidity guarantee for the common share

Chordate Medical Holding

Selskabsmeddelelse8.12.2025, 15.30

Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Selskabsmeddelelse18.11.2025, 18.40

Notice to the Extraordinary General Meeting in Chordate Medical Holding AB (publ)

Chordate Medical Holding

Selskabsmeddelelse18.11.2025, 18.30

The board of directors of Chordate proposes that the general meeting resolves on voluntary liquidation and delisting

Chordate Medical Holding

Selskabsmeddelelse21.8.2025, 06.30

Chordate Announces Cost Reduction and Focus on Company Sale

Chordate Medical Holding

Pressemeddelelse19.8.2025, 06.30

Chordate reports preliminary conclusions from long-term study on chronic migraine: PM010

Chordate Medical Holding

Selskabsmeddelelse17.7.2025, 13.45

Bulletin from the Extraordinary General Meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Selskabsmeddelelse30.6.2025, 16.45

Notice of Extraordinary General Meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Selskabsmeddelelse30.6.2025, 16.30

Chordate decides on a conditional directed new issue of Preference Shares of approximately SEK 2.55 million

Chordate Medical Holding

Pressemeddelelse27.6.2025, 06.30

Chordate presents conclusions from the second data monitoring of the ongoing open-label long-term study on chronic migraine: PM010

Chordate Medical Holding

Pressemeddelelse27.5.2025, 09.52

BioStock: Chordate Medical’s CEO comments on the quarterly report

Chordate Medical Holding

Selskabsmeddelelse23.5.2025, 06.30

Chordate Medical Holding AB (publ) Interim Report January-March 2025

Chordate Medical Holding

Selskabsmeddelelse21.5.2025, 14.15

Communiqué from the Annual General Meeting of Chordate Medical Holding AB (publ)

Chordate Medical Holding

Pressemeddelelse20.5.2025, 09.00

BioStock: BioStock: New distributor strengthens Chordate Medical’s investment in Saudi Arabia

Chordate Medical Holding

Pressemeddelelse13.5.2025, 08.45

Chordate Medical Expands Migraine Offering in Saudi Arabia – Appoints Additional Distributor

Chordate Medical Holding

Selskabsmeddelelse7.5.2025, 08.55

Chordate Medical terminates the liquidity provider agreement for the preference share

Chordate Medical Holding

Selskabsmeddelelse1.5.2025, 07.00

Change of Certified Adviser (CA) to Bergs Securities

Chordate Medical Holding

Inderes’ ansvarsfraskrivelse kan findes her. Detaljeret information om hver aktie, der aktivt overvåges af Inderes og HC Andersen Capital, er tilgængelig på de virksomhedsspecifikke sider på Inderes' hjemmeside. © Inderes Oyj. All rights reserved.